Development of a test to measure the immune response in patients with Covid-19

Development of a test to measure the immune response in patients with Covid-19 - CoV-Ak-Test

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021166

Enrollment

Registered

2020-03-27

Start date

2020-03-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: Persons with previous SARS CoV-2 infection

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adults with previous SARS CoV-2 infection

Exclusion criteria

Exclusion criteria: Pregnancy, individuals unable to provide informed consent

Design outcomes

Primary

Measure	Time frame
The study determines if the test identifies persons with previous infection by comparing with a gold standard test	—

Secondary

Measure	Time frame
Sensitivity and specificity of the test	—

Countries

Germany

Contacts

Public ContactChristian Jassoy

Institut für Medizinische Mikrobiologie und Virologie, Universitätsklinikum Leipzig

christian.jassoy@medizin.uni-leipzig.de0341 9714314

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026